BCM
INVZ icon

Bayesian Capital Management’s Innoviz Technologies INVZ Stock Holding History

Bayesian Capital Management’s Portfolio INVZ Stock Details INVZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-24,700
Closed -$22.9K – 856
2024
Q2 		$22.9K Buy
+24,700
New +$27.7K ﹤0.01% 679
2023
Q2 		– Sell
-20,800
Closed -$72.8K – 928
2023
Q1 		$72.8K Buy
+20,800
New +$92.2K 0.01% 702
2022
Q4 		– Sell
-22,179
Closed -$116K – 891
2022
Q3 		$116K Sell
22,179
-14,900
-40% -$71.4K 0.02% 581
2022
Q2 		$145K Buy
+37,079
New +$145K 0.03% 655

Other funds holding INVZ

Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
AC
Antara Capital New York $30.2K AUM 5.24% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $14.7B AUM 47% 1-Year Est. Return
CAC
Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return
IP
Interval Partners New York $3.82B AUM 27.38% 1-Year Est. Return
Mitsubishi UFJ Asset Management
Mitsubishi UFJ Asset Management Tokyo, Japan $149B AUM 24.71% 1-Year Est. Return

Bayesian Capital Management's INVZ Position: Q3 2024 in Review

Bayesian Capital Management sold out of Innoviz Technologies (INVZ) in Q3 2024, closing a stake of 24,700 shares — an estimated $22.9K sold.

Bayesian Capital Management first reported a position in INVZ in Q2 2022 and held it in 4 quarters. The position peaked at $145K in Q2 2022. 81 funds tracked by Wall St. Rank hold INVZ as of Q3 2024.

  • Bayesian Capital Management reported no remaining Innoviz Technologies position as of Q3 2024 after selling out during the quarter.
  • Bayesian Capital Management sold 24,700 Innoviz Technologies shares in Q3 2024, an estimated $22.9K.
  • Bayesian Capital Management first reported a position in Innoviz Technologies in Q2 2022 and held it in 4 quarters.
  • Bayesian Capital Management's Innoviz Technologies position peaked at $145K in Q2 2022.
  • 81 funds tracked by Wall St. Rank held Innoviz Technologies as of Q3 2024.

Based on Bayesian Capital Management's 13F filing for Q3 2024, filed 14 Nov 2024.